Unraveling the role of microRNA/isomiR network in multiple primary melanoma pathogenesis.
Journal
Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092
Informations de publication
Date de publication:
12 05 2021
12 05 2021
Historique:
received:
11
12
2020
accepted:
19
04
2021
revised:
19
04
2021
entrez:
13
5
2021
pubmed:
14
5
2021
medline:
15
10
2021
Statut:
epublish
Résumé
Malignant cutaneous melanoma (CM) is a potentially lethal form of skin cancer whose worldwide incidence has been constantly increasing over the past decades. During their lifetime, about 8% of CM patients will develop multiple primary melanomas (MPMs), usually at a young age and within 3 years from the first tumor/diagnosis. With the aim of improving our knowledge on MPM biology and pathogenesis, we explored the miRNome of 24 single and multiple primary melanomas, including multiple tumors from the same patient, using a small RNA-sequencing approach. From a supervised analysis, 22 miRNAs were differentially expressed in MPM compared to single CM, including key miRNAs involved in epithelial-mesenchymal transition. The first and second melanoma from the same patient presented a different miRNA profile. Ten miRNAs, including miR-25-3p, 149-5p, 92b-3p, 211-5p, 125a-5p, 125b-5p, 205-5p, 200b-3p, 21-5p, and 146a-5p, were further validated in 47 single and multiple melanoma samples. Pathway enrichment analysis of miRNA target genes revealed a more differentiated and less invasive status of MPMs compared to CMs. Bioinformatic analyses at the miRNA isoform (isomiR) level detected a panel of highly expressed isomiRs belonging to miRNA families implicated in human tumorigenesis, including miR-200, miR-30, and miR-10 family. Moreover, we identified hsa-miR-125a-5p|0|-2 isoform as tenfold over-represented in melanoma than the canonical form and differentially expressed in MPMs arising in the same patient. Target prediction analysis revealed that the miRNA shortening could change the pattern of target gene regulation, specifically in genes implicated in cell adhesion and neuronal differentiation. Overall, we provided a putative and comprehensive characterization of the miRNA/isomiR regulatory network of MPMs, highlighting mechanisms of tumor development and molecular features differentiating this subtype from single melanomas.
Identifiants
pubmed: 33980826
doi: 10.1038/s41419-021-03764-y
pii: 10.1038/s41419-021-03764-y
pmc: PMC8115306
doi:
Substances chimiques
MicroRNAs
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
473Références
Int J Cancer. 2017 Dec 1;141(11):2243-2252
pubmed: 28799271
Science. 2002 Oct 18;298(5593):601-4
pubmed: 12228721
Mol Oncol. 2019 Jan;13(1):74-98
pubmed: 30499222
Eur J Cancer. 2005 Sep;41(14):2040-59
pubmed: 16125929
JAMA. 2005 Oct 5;294(13):1647-54
pubmed: 16204664
Nat Cell Biol. 2008 May;10(5):593-601
pubmed: 18376396
J Am Acad Dermatol. 2018 Aug;79(2):238-244
pubmed: 29499295
J Am Acad Dermatol. 2017 Nov;77(5):893-901
pubmed: 28818438
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
J Transl Med. 2014 May 08;12:117
pubmed: 24885594
J Am Acad Dermatol. 2016 Mar;74(3):395-407; quiz 408-10
pubmed: 26892650
Cancer Cell. 2013 Oct 14;24(4):466-80
pubmed: 24075834
Melanoma Res. 2018 Apr;28(2):166-169
pubmed: 29485552
Br J Dermatol. 2018 Jan;178(1):e44-e45
pubmed: 28755438
RNA. 2012 Feb;18(2):177-92
pubmed: 22190743
Int J Oncol. 2015 Feb;46(2):459-64
pubmed: 25405282
Can Med Assoc J. 1968 Jul 6;99(1):17-21
pubmed: 5663000
Tohoku J Exp Med. 2014;234(1):57-65
pubmed: 25175033
Am J Pathol. 2000 May;156(5):1515-25
pubmed: 10793063
Mol Aspects Med. 2019 Dec;70:57-71
pubmed: 31558294
J Am Acad Dermatol. 2016 Feb;74(2):325-32
pubmed: 26775776
J Biol Chem. 2011 Nov 11;286(45):39172-8
pubmed: 21940630
Genome Res. 2010 Oct;20(10):1398-410
pubmed: 20719920
PLoS One. 2010 Oct 04;5(10):
pubmed: 20957176
Genome Biol. 2014;15(12):550
pubmed: 25516281
Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):949-58
pubmed: 18398036
J Cell Biochem. 2007 Jul 1;101(4):816-29
pubmed: 17243120
Biomed Res Int. 2018 May 29;2018:9623412
pubmed: 30003109
Pathology. 2007 Jun;39(3):305-18
pubmed: 17558857
JAMA Dermatol. 2019 Sep 1;155(9):1049-1056
pubmed: 31241717
J Pathol. 2011 Sep;225(1):43-53
pubmed: 21630269
Nat Rev Mol Cell Biol. 2005 May;6(5):376-85
pubmed: 15852042
Cancer Res. 2007 Apr 1;67(7):3450-60
pubmed: 17409456
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61
pubmed: 16461460
BMC Cancer. 2019 Aug 5;19(1):772
pubmed: 31382929
J Eur Acad Dermatol Venereol. 2012 Jul;26(7):882-8
pubmed: 21819449
Genome Biol. 2011 Dec 30;12(12):R126
pubmed: 22208850
Cell. 1993 Dec 3;75(5):843-54
pubmed: 8252621
Tumour Biol. 2012 Aug;33(4):1223-30
pubmed: 22392501
Histopathology. 2016 Jul;69(1):63-71
pubmed: 26619071
Br J Cancer. 2013 Mar 5;108(4):973-82
pubmed: 23299537
Cell Death Differ. 2014 Aug;21(8):1250-61
pubmed: 24769727
Genes Dev. 2008 Apr 1;22(7):894-907
pubmed: 18381893
Nat Genet. 1996 Dec;14(4):482-6
pubmed: 8944033
Oncotarget. 2014 Sep 30;5(18):8790-802
pubmed: 25229428
Ann Transl Med. 2015 Sep;3(15):210
pubmed: 26488006
Nucleic Acids Res. 2017 Apr 7;45(6):2973-2985
pubmed: 28206648
J Am Acad Dermatol. 2012 Dec;67(6):1257-64
pubmed: 22841127
Cancer. 2012 Sep 1;118(17):4184-92
pubmed: 22246969
Cells. 2019 Dec 25;9(1):
pubmed: 31881725
Stem Cells Dev. 2017 Aug 1;26(15):1090-1099
pubmed: 28494695
J Pathol. 1998 Dec;186(4):350-5
pubmed: 10209482
J Cell Sci. 1994 Apr;107 ( Pt 4):983-92
pubmed: 8056851
Bioinformatics. 2012 Dec 15;28(24):3322-3
pubmed: 23074262
Bioinformatics. 2011 Apr 1;27(7):1011-2
pubmed: 21278192
Mol Cancer Ther. 2008 Nov;7(11):3642-53
pubmed: 19001446
Mol Cell Biol. 2009 Oct;29(19):5290-305
pubmed: 19635812
Br J Dermatol. 2012 Jun;166(6):1184-97
pubmed: 22332917
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
J Clin Invest. 2003 Dec;112(12):1776-84
pubmed: 14679171
Cell Death Differ. 2010 Feb;17(2):209-14
pubmed: 19461655
Mol Biol Rep. 2010 Jul;37(6):2579-86
pubmed: 19728149
J Exp Clin Cancer Res. 2019 Mar 28;38(1):137
pubmed: 30922374
J Am Acad Dermatol. 1998 Sep;39(3):422-7
pubmed: 9738776
Genes Dev. 2010 May 15;24(10):992-1009
pubmed: 20413612
PLoS Genet. 2016 Aug 10;12(8):e1006247
pubmed: 27508495
Cancer. 2002 Apr 15;94(8):2248-55
pubmed: 12001124
J Natl Cancer Inst. 2004 May 19;96(10):785-95
pubmed: 15150307
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D140-4
pubmed: 16381832
Arch Dermatol. 2003 Aug;139(8):1013-8
pubmed: 12925389
Science. 2002 Oct 18;298(5593):597-600
pubmed: 12228720
G Ital Dermatol Venereol. 2017 Jun;152(3):262-265
pubmed: 28121081
G Ital Dermatol Venereol. 2020 Mar 27;:
pubmed: 32221274
Development. 2015 Feb 15;142(4):620-32
pubmed: 25670789
Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9740-4
pubmed: 15210942
Ann Surg Oncol. 2018 Aug;25(8):2105-2110
pubmed: 29850954
Biochem Res Int. 2013;2013:506731
pubmed: 23762558
Cancer Biol Ther. 2016;17(1):83-90
pubmed: 26650572